Canton Strategic Holdings Inc. Announces Tokenised Share Listing
Canton Strategic Holdings Inc. (NASDAQ: CNTN) has disclosed plans to launch tokenised shares on the Canton Network’s Tokenised Securities Venue (TSV) in early November 2026.
Key Details of the Tokenisation Initiative
- Venue: TSV, a permissioned platform for tokenised National Market System (NMS) stocks on the Canton Network.
- Timing: Trading is expected to commence on Monday, November 2, 2026, pending regulatory and operational finalisation.
- Tokeniser: Fairmint, through its SEC‑registered subsidiary Fairmint TA, will issue the tokenised shares, maintain ownership records, and ensure transfer compliance.
- Trading Features:
- 24‑hour trading availability via TSV’s automated market maker.
- Atomic settlement enabled by the Tradecraft protocol.
- Shares will carry the same shareholder rights as the Nasdaq‑listed common stock.
Regulatory Context
- The tokenisation effort follows TSV’s notification to the U.S. Securities and Exchange Commission under the 17 September Innovation Exemption framework.
- TSV claims it is the first to formally notify the SEC of intent to operate a tokenised securities venue, positioning the forthcoming listing as a standard‑setting event.
Company Leadership Statements
- Mark Wendland, Chairman and CEO of Canton Strategic Holdings, stated that tokenisation “creates more efficient access to equity markets for investors and greater transparency for issuers.”
- Ali Abrar, CEO of TSV, emphasized the importance of establishing a compliant, onshore platform for tokenised equities.
Market Reaction
- Following the announcement, Canton Strategic Holdings shares increased 0.49%, trading at $2.050 on the Nasdaq.
Summary
Canton Strategic Holdings Inc. is poised to become the first publicly traded U.S. company to offer tokenised shares that are tradable 24/7 with instant settlement. The initiative leverages the Canton Network’s blockchain infrastructure, the Fairmint on‑chain transfer agent, and TSV’s compliant venue to deliver a new class of equity product that aligns with the SEC’s Innovation Exemption.




